Nov 30, 2017 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that new data on the Company’s first FDA-approved anticoagulant, betrixaban, and its two investigational...
HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Ohio
Nov 30, 2017 13:00 pm UTC| Business
TAMPA, Fla., Nov. 30, 2017 -- HCI Group, Inc. (NYSE:HCI) announced today that its wholly-owned insurance subsidiary, Homeowners Choice Property Casualty Insurance Company, Inc., has received regulatory approval to...
BioScrip to Host Meetings at the Mizuho Investor Conference
Nov 30, 2017 13:00 pm UTC| Business
DENVER, Nov. 30, 2017 -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf,...
TechGirlz Survey Finds Middle Schools Lack Technology Offerings for Girls
Nov 30, 2017 13:00 pm UTC| Business
PHILADELPHIA, Nov. 30, 2017 -- As part of the run-up to Computer Science Education Week and in anticipation of the Hour of Code activities planned for next week, TechGirlz today shared insights from its annual survey of...
Jingle All the Way to the Pensacola Bay Area this Winter
Nov 30, 2017 13:00 pm UTC| Business
Pensacola, FL, Nov. 30, 2017 -- Nothing says happy holidays like hand picking that perfect gift for a loved one and what better place to do it than one of Expedia’s Best American Towns for Holiday Shopping....
Nov 30, 2017 12:50 pm UTC| Business
NEW YORK, Nov. 30, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NRG Energy, Inc....
Nov 30, 2017 12:50 pm UTC| Business
NEW YORK, Nov. 30, 2017 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Duke Energy...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update